These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 28454690

  • 1. Placental soluble fms-like tyrosine kinase expression in small for gestational age infants and risk for adverse outcomes.
    Spiel M, Salahuddin S, Pernicone E, Zsengeller Z, Wang A, Modest AM, Karumanchi SA, Hecht JL.
    Placenta; 2017 Apr; 52():10-16. PubMed ID: 28454690
    [Abstract] [Full Text] [Related]

  • 2. Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.
    Garcia-Manau P, Mendoza M, Bonacina E, Garrido-Gimenez C, Fernandez-Oliva A, Zanini J, Catalan M, Tur H, Serrano B, Carreras E.
    Acta Obstet Gynecol Scand; 2021 Jan; 100(1):119-128. PubMed ID: 32860218
    [Abstract] [Full Text] [Related]

  • 3. Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction.
    Nevo O, Many A, Xu J, Kingdom J, Piccoli E, Zamudio S, Post M, Bocking A, Todros T, Caniggia I.
    J Clin Endocrinol Metab; 2008 Jan; 93(1):285-92. PubMed ID: 17956955
    [Abstract] [Full Text] [Related]

  • 4. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM, Roland MC, Henriksen T, Michelsen TM.
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [Abstract] [Full Text] [Related]

  • 5. Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks' gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study.
    MacDonald TM, Tran C, Kaitu'u-Lino TJ, Brennecke SP, Hiscock RJ, Hui L, Dane KM, Middleton AL, Cannon P, Walker SP, Tong S.
    BMC Pregnancy Childbirth; 2018 Aug 31; 18(1):354. PubMed ID: 30170567
    [Abstract] [Full Text] [Related]

  • 6. Angiogenic factors at diagnosis of late-onset small-for-gestational age and histological placental underperfusion.
    Triunfo S, Lobmaier S, Parra-Saavedra M, Crovetto F, Peguero A, Nadal A, Gratacos E, Figueras F.
    Placenta; 2014 Jun 31; 35(6):398-403. PubMed ID: 24746262
    [Abstract] [Full Text] [Related]

  • 7. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
    Rizos D, Eleftheriades M, Karampas G, Rizou M, Haliassos A, Hassiakos D, Vitoratos N.
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec 31; 171(2):225-30. PubMed ID: 24035323
    [Abstract] [Full Text] [Related]

  • 8. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
    Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, Bodnar LM, Crombleholme WR, Ness RB, Roberts JM, Hubel CA.
    J Clin Endocrinol Metab; 2005 Aug 31; 90(8):4895-903. PubMed ID: 15886253
    [Abstract] [Full Text] [Related]

  • 9. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
    Triunfo S, Crovetto F, Crispi F, Rodriguez-Sureda V, Dominguez C, Nadal A, Peguero A, Gratacos E, Figueras F.
    Placenta; 2016 Jun 31; 42():44-50. PubMed ID: 27238713
    [Abstract] [Full Text] [Related]

  • 10. Placental findings in late-onset SGA births without Doppler signs of placental insufficiency.
    Parra-Saavedra M, Crovetto F, Triunfo S, Savchev S, Peguero A, Nadal A, Parra G, Gratacos E, Figueras F.
    Placenta; 2013 Dec 31; 34(12):1136-41. PubMed ID: 24138874
    [Abstract] [Full Text] [Related]

  • 11. Changes in uterine artery Doppler velocimetry and circulating angiogenic factors in the first half of pregnancies delivering a small-for-gestational-age neonate.
    Triunfo S, Crovetto F, Rodriguez-Sureda V, Scazzocchio E, Crispi F, Dominguez C, Gratacos E, Figueras F.
    Ultrasound Obstet Gynecol; 2017 Mar 31; 49(3):357-363. PubMed ID: 27241056
    [Abstract] [Full Text] [Related]

  • 12. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
    Bakalis S, Peeva G, Gonzalez R, Poon LC, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2015 Oct 31; 46(4):446-51. PubMed ID: 25826154
    [Abstract] [Full Text] [Related]

  • 13. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
    Baltajian K, Bajracharya S, Salahuddin S, Berg AH, Geahchan C, Wenger JB, Thadhani R, Karumanchi SA, Rana S.
    Am J Obstet Gynecol; 2016 Jul 31; 215(1):89.e1-89.e10. PubMed ID: 26827880
    [Abstract] [Full Text] [Related]

  • 14. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks.
    Bakalis S, Gallo DM, Mendez O, Poon LC, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2015 Aug 31; 46(2):208-15. PubMed ID: 25826797
    [Abstract] [Full Text] [Related]

  • 15. Serum placental growth factor and soluble fms-like tyrosine kinase 1 at mid-gestation in healthy women: Association with small-for-gestational-age neonates.
    Furuta I, Umazume T, Kojima T, Chiba K, Nakagawa K, Hosokawa A, Ishikawa S, Yamada T, Morikawa M, Minakami H.
    J Obstet Gynaecol Res; 2017 Jul 31; 43(7):1152-1158. PubMed ID: 28422347
    [Abstract] [Full Text] [Related]

  • 16. Prediction of small-for-gestational-age neonates: screening by placental growth factor and soluble fms-like tyrosine kinase-1 at 35-37 weeks.
    Fadigas C, Peeva G, Mendez O, Poon LC, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2015 Aug 31; 46(2):191-7. PubMed ID: 25825848
    [Abstract] [Full Text] [Related]

  • 17. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S, Kaitu'u-Lino TJ, Onda K, Beard S, Hastie R, Binder NK, Cluver C, Tuohey L, Whitehead C, Brownfoot F, De Silva M, Hannan NJ.
    Hypertension; 2015 Nov 31; 66(5):1073-81. PubMed ID: 26324507
    [Abstract] [Full Text] [Related]

  • 18. Early pregnancy maternal and fetal angiogenic factors and fetal and childhood growth: the Generation R Study.
    Bergen NE, Bouwland-Both MI, Steegers-Theunissen RP, Hofman A, Russcher H, Lindemans J, Jaddoe VW, Steegers EA.
    Hum Reprod; 2015 Jun 31; 30(6):1302-13. PubMed ID: 25854264
    [Abstract] [Full Text] [Related]

  • 19. An sFlt-1:PlGF ratio of 655 is not a reliable cut-off value for predicting perinatal outcomes in women with preeclampsia.
    Stolz M, Zeisler H, Heinzl F, Binder J, Farr A.
    Pregnancy Hypertens; 2018 Jan 31; 11():54-60. PubMed ID: 29523274
    [Abstract] [Full Text] [Related]

  • 20. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
    Rajakumar A, Michael HM, Rajakumar PA, Shibata E, Hubel CA, Karumanchi SA, Thadhani R, Wolf M, Harger G, Markovic N.
    Placenta; 2005 Aug 31; 26(7):563-73. PubMed ID: 15993706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.